Not checkedNot checked for notices yet.
Proteinase-nicked IgGs: an unanticipated target for tumor immunotherapy
Robert E. Jordan, Xuejun Fan, Georgina Salazar and 2 more
OncoImmunology · 2018
doi:10.1080/2162402x.2018.1480300 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
The host immune system adopts multiple mechanisms involving antibodies to confront cancer cells. Accordingly, anti-tumor mAbs have become mainstays in cancer treatment. However, neither host immunity nor mAb therapies appear capable of controlling tumor growth in all cases. Structural instability of IgG was overlooked as a factor contributing to immunosuppression in the tumor microenvironment. Recently, physiological proteinases were identified that disable IgG immune effector functions. Evidence shows that these proteinases cause localized IgG impairment by selective cleavage of a single IgG peptide bond in the hinge-region. The recognition of IgG cleavage in the tumor microenvironment provides alternatives for tumor immunotherapy.
Abstract licence: CC BY-NC
References51
40 more references, whose wording the paper’s licence keeps private.
All 51 referencesReads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.